Bisoprolol makes no difference in moderately severe COPD
In the treatment of patients with moderately severe chronic obstructive pulmonary disease (COPD), the use of bisoprolol has no significant effect on overall cardiorespiratory health, all-cause mortality, or serious cardiorespiratory events when compared with placebo, as shown in a phase III study.
